WHO declared end to mpox public health emergency
On May 11, 2023, the World Health Organization announced it was ending a 10-month-long global health emergency for…
-
-
NIH scientists develop mouse model to study Mpox virulence
On Feb. 14, 2023, scientists from the National Institute of Allergy and Infectious Diseases announced they had developed…
-
FDA authorized first Mpox point-of-care test
On Feb. 10, 2023, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for…
-
WHO recommended new name for mpox disease
On Nov. 28, 2022, the World Health Organization (WHO) announced that following a series of consultations with global…
-
University of Missouri study found Mpox mutations caused virus to spread rapidly, evade drugs and vaccines
On Nov. 3, 2022, researchers have identified the specific mutations in the mpox virus that contribute to its…
-
FDA Authorized PCR-Based Mpox Test
On Oct. 7, 2022, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to…
-
Clinical trial evaluating Mpox vaccine began
On Sept. 8, 2022, a clinical trial evaluating alternative strategies for administering the JYNNEOS mpox vaccine to increase…
-
FDA authorized Quest Diagnostics’ proprietary Mpox test for emergency use
On Sept. 7, 2022, Quest Diagnostics announced that it had received emergency use authorization (EUA) from the U.S….
-
Biotechnology | Infectious Disease | NIH | U.S. Congress | USDA | Vaccine
The White House announced actions to combat Mpox outbreak
On Aug. 18, 2022, the White House announced that the U.S. Department of Health and Human Services (HHS)…
-
WHO experts gave Mpox virus variants new names
On Aug. 12, 2022, a group of global experts convened by WHO agreed on new names for monkeypox…
-
FDA authorized Emergency Use of JYNNEOS Mpox vaccine
On Aug. 9, 2022, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization for the…
-
Biotechnology | Diagnostics | FDA | Infectious Disease | NIH | Non-Profit Research | U.S. Congress | Vaccine
U.S. Department of Health and Human Services declared Mpox a public health emergency
On Aug. 4, 2022, the U.S. Department of Health and Human Services declared the ongoing spread of monkeypox…
-
Labcorp first national laboratory to offer Mpox test
On Jul. 6, 2022, LabCorp announced that it had begun testing for mpox using the U.S. Centers for…
-
Roche developed unique PCR tests to detect the mpox virus
On May 25, 2022, Roche and its subsidiary TIB Molbiol announced they had developed three unique LightMix Modular…
-
WHO announced nulti-country mpox outbreak in non-endemic countries
On May 21, 2022, the World Health Organization (WHO) announced that since May 13, 2022, cases of mpox…
-
CDC and health partners responded to Mpox case in the U.S.
On May 18, 2022, scientists at the Centers for Disease Control and Prevention (CDC) announced that they were…
-
WHO informed of a confirmed case of mpox in an individual who travelled from the United Kingdom to Nigeria
On May 7, 2022, the World Health Organization (WHO) was informed of a confirmed case of Mpox in…
-
Imported Mpox case reported in Maryland
On Nov. 17, 2021, scientists at the Centers for Disease Control and Prevention (CDC) announced they were collaborating…
-
SIGA announced collaboration with Oxford University to expanded Access Protocol for Use of TPOXX in Central African Republic
On Jul. 29, 2021, SIGA Technologies announced that it had entered into a collaboration with Oxford University in…
-
CDC and Texas Health Officials confirmed First Mpox In U.S. traveler
On Jul. 13, 2021, an emergency department (ED) physician in Dallas evaluated an early middle-aged man with a…
-
SIGA supplied TPOXX (Tecovirimat) as compassionate treatment for Mpox case in the Central African Republic
On Jul. 29, 2021, SIGA Technologies announced that it had entered into a collaboration with Oxford University in…
-
Biotechnology | Diagnostics | Infectious Disease | NIH | Non-Profit Research | Therapeutics | Vaccine
PNNL lands $10.3 million NIH biodefense contract to unlock proteomes of salmonella and pox
On Sept. 14, 2004, Pacific Northwest National Laboratory (PNNL) announced it had received a $10.3 million biodefense contract…
-
Biotechnology | CDC | Diagnostics | Genomics | Infectious Disease | Therapeutics | Vaccine
The CDC responded to U.S. outbreak of mpox, first human Mpox outside of Africa
On Jul. 8, 2003, the U.S. Centers for Disease Control and Prevention (CDC) announced a total of 71…
-
first human case of mpox Reported in the Democratic Republic of Congo
In 1970, the first cases of mpox were observed in the Democratic Republic of Congo, then spread to…
-
mpox was first discovered
In 1958, mpox (MPVX) was first discovered when two nonfatal outbreaks of a pox-like disease were reported in…
